inositol has been researched along with Basedow Disease in 2 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patients had significantly reduced total choline and myo-inositol in the acute phase of Graves' thyrotoxicosis compared with the healthy volunteers." | 9.10 | Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease. ( Danielsen, ER; Elberling, TV; Feldt-Rasmussen, U; Rasmussen, AK; Thomsen, C; Waldemar, G, 2003) |
| "Graves' disease is an autoimmune disease of the thyroid gland." | 5.35 | Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients. ( Danielsen, ER; Dock, J; Elberling, TV; Feldt-Rasmussen, U; Hørding, M; Perrild, H; Rasmussen, AK; Thomsen, C; Waldemar, G, 2008) |
| " The patients had significantly reduced total choline and myo-inositol in the acute phase of Graves' thyrotoxicosis compared with the healthy volunteers." | 5.10 | Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease. ( Danielsen, ER; Elberling, TV; Feldt-Rasmussen, U; Rasmussen, AK; Thomsen, C; Waldemar, G, 2003) |
| "Graves' disease is an autoimmune disease of the thyroid gland." | 1.35 | Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients. ( Danielsen, ER; Dock, J; Elberling, TV; Feldt-Rasmussen, U; Hørding, M; Perrild, H; Rasmussen, AK; Thomsen, C; Waldemar, G, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elberling, TV | 2 |
| Danielsen, ER | 2 |
| Rasmussen, AK | 2 |
| Feldt-Rasmussen, U | 2 |
| Waldemar, G | 2 |
| Thomsen, C | 2 |
| Dock, J | 1 |
| Hørding, M | 1 |
| Perrild, H | 1 |
1 trial available for inositol and Basedow Disease
| Article | Year |
|---|---|
Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease.
Topics: Acute Disease; Adult; Brain; Choline; Female; Frontal Lobe; Graves Disease; Humans; Inositol; Magnet | 2003 |
1 other study available for inositol and Basedow Disease
| Article | Year |
|---|---|
Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients.
Topics: Adult; Aspartic Acid; Choline; Dipeptides; Female; Glutamic Acid; Glutamine; Graves Disease; Humans; | 2008 |